Skip to main content
Top

Drugs

Issue 3/2022

Content (11 Articles)

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, Lindsay R. Meredith, Brian Hurley, Karen Miotto, Artha J. Gillis, Lara A. Ray

Pharmacologic Management of Persistent Pain in Cancer Survivors

  • Open Access
  • Opioids
  • Review Article

Paul Glare, Karin Aubrey, Amitabh Gulati, Yi Ching Lee, Natalie Moryl, Sarah Overton

Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature

Luis F. Rendon, Ishaan A. Tewarie, David J. Cote, Aaron Gabriel, Timothy R. Smith, Marike L. D. Broekman, Rania A. Mekary

Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases

Tian Li, Rui Providencia, Wenhua Jiang, Manling Liu, Lu Yu, Chunhu Gu, Alex Chia Yu Chang, Heng Ma

Maribavir: First Approval

Connie Kang

Efgartigimod: First Approval

Young-A Heo

Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”

Mario Gennaro Mazza, Benedetta Vai, Livia De Picker, Francesco Benedetti, Raffaella Zanardi

Correction to: Ocular Toxicity of Targeted Anticancer Agents

Blake H. Fortes, Prashant D. Tailor, Lauren A. Dalvin

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images